08:45 - 10:05
Phage Therapy 1: updates on treating human bacterial pathogens
Main Auditorium
Oral Presentations (invited speaker)
08:45 - 09:00
Phage Therapy I-T10-Oft-01
Offered talk - 15 min
Bacteriophage evolution during phage therapy, the story of a ménage à trois
 
Luisa De Sordi1, Varun Khanna2, Laurent Debarbieux1
1Department of Microbiology, Institut Pasteur, Paris, France, 2Institut Pasteur Hub Bioinformatique et Biostatistique - USR 3756 IP CNRS, Paris, France
09:00 - 09:25
Phage Therapy I-T10-IvT-02
Invited talk - 25 min
PHAGOBURN trial: primary endpoint evaluation in phage therapy
 
Jerome Gabard1, Thomas LeClerc2, Laurent Bretaudeau6, Isabelle Arnaud6, Goulven Theze10, Gregory Rest4, Helene Blois1, Yok Ai Que4, Christine Cotton10, Serge Jennes5, Jean-Paul Pirnay5, et al.
1Pherecydes Pharma, Romainville, France, 2Percy, Clamart, France, 3St. Joseph/St Luc, Lyon, France, 4CHUV, Lausanne, Switzerland, 5Queen Astrid military hospital, Brussels, Belgium, 6CLEAN CELLS, BOUFFERE, France, 7CHU de Liege, Liege, Belgium, 8CHU Nantes, Nantes, France, 9Grand Charleroi, Charleroi, Belgium, 10Static Pharmaceuticals, MANDELIEU, France
09:25 - 09:40
Phage Therapy I-T10-Oft-03
Offered talk - 15 min
Resolving Diabetic Foot Infections: Compassionate use of Staph Phage Sb-1
 
Randy Fish1, Elizabeth Kutter1, 2, Gordon Wheat1, Kuhl Sarah1
1Phagebiotics Research Foundation, Olympia, WA, United States, 2Evergreen State College, Olympia, WA, United States, 3Eliava Institute, Tbilisi, Georgia
09:40 - 10:05
Phage Therapy I-T10-IvT-04
Invited talk - 25 min
Has the Caudovirales outlived its taxonomic usefulness?
 
Andrew Kropinski1, Evelien Adriaenssens2
1University of Guelph, Guelph, Canada, 2Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom